Generation of primary myotubes

Primary myoblast cell lines were generated from the hind limb and forelimb muscles of neonatal heterozygous (Het) and homozygous (Hom) F2 R163C C57Bl6/129svJ mice and their WT littermates (Rando and Blau, 1994;Yang et al., 2006). Myoblasts were differentiated into myotubes by withdrawal of growth factors as described previously (Yang et al., 2003). Animals were housed, fed, and sacrificed according to the standards set by the Harvard Medical School Institutional Animal Care and Use Committee.

Ca²⁺ imaging

Differentiated WT and R163C myotubes were loaded with 5 µM Fluo-4-AM (Invitrogen) at 37°C for 30 min in mammalian Ringer’s solution as described previously (Yang et al., 2006). The myotubes were then washed several times with mammalian Ringer’s solution and transferred to a microscope (Nikon). Fluorescence emission was measured at 516 nm with a long-pass filter using a 40×, 1.3 NA objective lens. Data were collected with a 12-bit digital-intensified CCD at 23 fps (Mega12; Stanford Photonics) from regions consisting of 8–12 individual cells per well and analyzed using QED software (QED Imaging). The magnitude of integrated Ca²⁺ transient (defined by the average area under the Ca²⁺ transient during a 3-min depolarization elicited by elevating [K⁺] in the extracellular medium) was compared among genotypes.

Intracellular recording

Single-barrel capillary tubing (1.5 mm OD; TW150F-4; WPI) containing an internal filament was used in the construction of microelectrodes for measuring the resting membrane potential. The pipettes were backfilled with 3 M KCl (resistance of ∼15 MΩ) and used to impale individual WT and R163C myotubes to measure membrane potential (at room temperature) before and during the time that myotubes were incubated in 60 mM K⁺ for 180 s. Results were discarded if tip resistance was altered by cell membrane penetration or from myotubes with resting potential values less negative than −60 mV.

Experimental protocols for Ca²⁺ transients

WT, R163C Het, or Hom R163C myotubes were exposed to high external potassium ([K⁺]_e) solutions in ascending or descending concentrations (10, 20, 40, and 60 mM KCl) for 180 s for each concentration separated by 180 s of rest. The concentration of 60 mM K⁺ was chosen for the remaining experiments because we have found that this concentration of K⁺ elicits a maximum Ca²⁺ response in skeletal muscle myotubes (Yang et al., 2007a). WT and Hom R163C myotubes were exposed to 20 mM caffeine for 10 s, and 180 s later to 60 mM [K⁺]_e for 180 s. During the 180-s period that the cell was depolarized, a second 10-s application of 20 mM caffeine was applied at intervals ranging from 20 to 200 s after the beginning of the 60-mM [K⁺]_e application. WT and R163C myotubes were exposed to 60 mM [K⁺]_e in the presence of 1.8 × 10⁻³ M Ca²⁺ (normal Ca²⁺) or 8.7 × 10⁻⁶ M Ca²⁺/5 mM Mg²⁺ (low Ca²⁺) solutions. The exposure to the low Ca²⁺ solution was done for 10 s before depolarization with 60 mM [K⁺]_e. WT and Hom R163C myotubes were exposed either to 10 µM nifedipine or 20 µM SKF-96365 for 10 s before depolarization with 60 mM [K⁺]_e. This time was chosen to minimize any effect on the amplitude of the Ca²⁺ transient that we observed with longer incubation times. WT and R163C Het and Hom myotubes were exposed to 60 mM [K⁺]_e first with normal Ca²⁺ solution, allowed to recover for 10 min, then with low Ca²⁺ solution, allowed to recover for 10 min, and then finally with low Ca²⁺ solution supplemented with 2 mM [Ni²⁺]_e; the responses were compared. WT and R163C Het and Hom myotubes were exposed to 60 mM [K⁺]_e for 10 s, and then the Ca²⁺ transient was interrupted by replacing the high [K⁺]_e solution with normal mammalian Ringer’s solution, followed by a second application of 60 mM [K⁺]_e 3, 5, or 10 s later.

Manganese quench

Differentiated primary WT or R163C Hom myotubes were loaded with 5 mM Fura-2 AM (Invitrogen) for 30 min at 37°C and washed four times for 10 min, each time in imaging buffer. After a baseline was established, the external solution was switched to a Ca²⁺-free buffer containing a final concentration of 500 µM Mn²⁺ (in the presence of 5 mM external Mg²⁺) with or without the addition of 2 mM Ni²⁺, and then stimulated with 60 mM KCl. The cells were continuously imaged before and after KCl stimulation at an excitation wavelength of 360 ± 3 nm (the isosbestic point of Fura-2), and fluorescence intensity was monitored with a 510-nm long-pass filter through a 40× quartz objective using an intensified CCD camera (see above). Data were collected from 3–10 individual cells simultaneously at 15 frames per second. The upward deflection that is seen in all raw traces shown indicates the application of KCl and is an artifact caused by intracellular Ca²⁺ release because it is not possible to be precisely at the isosbestic point of Fura-2 using any filter system.

Solutions

The composition of standard Ringer’s solution was (in mM): 125 NaCl, 5 KCl, 2 CaCl₂, 1.2 MgSO₄, 5 glucose, and 25 HEPES, pH 7.4. Pilot experiments were conducted with Het and Hom R163C and WT myotubes exposed to [K⁺]_e solutions in which the [K⁺] × [Cl⁻] was either maintained constant or not maintained constant. No significant difference was observed in the amplitude and kinetics of the Ca²⁺ transients elicited by the high K⁺ solutions under either condition; therefore, we did not maintain the [K⁺] × [Cl⁻] in the solutions used experimentally (Hodgkin and Horowicz, 1959). The NaCl concentrations were adjusted to maintain a total ionic strength [Na⁺] + [K⁺] constant at 130 mM. Caffeine was prepared by adding the desired amount directly into the Ringer’s solution or the corresponding high [K⁺]_e solutions.

Statistical analysis

All values are expressed as mean ± SEM, with the numbers in parentheses indicating the number of myotubes tested. Statistical analysis was performed using pairedt test, unpairedt test, or one-way analysis of variance coupled with Tukey’st test for multiple measurements to determine significance (P < 0.05). Rates of decay were calculated using the formula y(t) = ae^−kt.

The MH-causing R163C RyR1 mutation slows the decay of Ca²⁺ transients during prolonged depolarization

Fig. 1 shows representative Ca²⁺ transients elicited from WT and R163C Het and Hom myotubes by a random order titration of [K⁺]_e (10, 20, 40, and 60 mM). The K⁺-evoked Ca²⁺ transients from the myotubes of all three genotypes had a magnitude and time course that was dependent on [K⁺]_e. The threshold [K⁺]_e needed to elicit Ca²⁺ transients was 10 mM for Het and Hom R163C myotubes, whereas it was 20 mM in WT cells (P < 0.05, Tukey’s multiple tests;Fig. 1). Independent of the [K⁺]_e concentration, the integrated magnitude of the Ca²⁺ transients showed the rank order as Hom >> Het > WT. WT and R163C myotubes respond to prolonged [K⁺]_e exposures with an initial brief Ca²⁺ peak followed by a spontaneous exponential decay. This spontaneous decay was seen in all myotubes tested, despite the fact that depolarization of the plasma membrane was maintained throughout the exposure. At the maximum [K⁺]_e concentration tested (60 mM), the average integrals of the Ca²⁺ transients were 1.8 and 3.6 times greater in Het and Hom R163C myotubes in relation to WT myotubes, and the peak rates of Ca²⁺ transient decay were 0.107 ± 0.004 s⁻¹ (n = 11), 0.068 ± 0.004 s⁻¹ (n = 13), and 0.037 ± 0.003 s⁻¹ (n = 17) in WT and R163C Het and Hom myotubes, respectively (P < 0.001).

To make certain that membrane depolarization evoked by 60 mM [K⁺]_e was maintained at similar potentials among the myotubes used in the study, the membrane potential was recorded from each genotype before and during the 180-s depolarization. There was no significant difference (P > 0.05, nonpairedt test) in resting membrane potentials or potentials obtained during the 60-mM [K⁺]_e challenge, and the level of depolarization was sustained for the duration of the [K⁺]_e test, regardless of the myotube’s genotype (Table I).

Decay of the Ca²⁺ transient during prolonged depolarization is not due to SR Ca²⁺ depletion or RYR1 inactivation

To test the hypothesis that the spontaneous decay of the K⁺-evoked Ca²⁺ transients was the result of SR Ca²⁺ depletion or inactivation of RYR1 by high myoplasmic Ca²⁺ concentrations, we elicited SR Ca²⁺ release with a 10-s application of 20 mM caffeine before, during, and after exposure to 60 mM [K⁺]_e.Fig. 2 shows the response to caffeine at different intervals (20, 40, 80, 120, 160, and 200 s) after initiating a 180-s challenge to 60 mM [K⁺]_e. At each interval, caffeine produced a robust release of Ca²⁺ whose amplitude was not significantly different (P > 0.1) than that measured before the [K⁺]_e challenge, regardless of genotype. Thus, decay of the [K⁺]_e-triggered Ca²⁺ transient in WT and Hom R163C myotubes does not appear to be related to either depletion of SR Ca²⁺ stores (Hodgkin and Horowicz, 1960b) or inactivation of RYR1 (Smith et al., 1985;Suarez-Isla et al., 1986;Simon et al., 1991;Jong et al., 1995).

Removal of external Ca²⁺ accelerates Ca²⁺ transient decay

It is well established that a relatively short exposure to a low [Ca²⁺]_e medium has no effect on the peak K⁺ contracture tension; however, it greatly shortens the contracture time course, reducing the duration of the plateau and increasing the relaxation rate (Bianchi and Shanes, 1959;Frank, 1960;Caputo and Gimenez, 1967). Recently, the L-type current has been identified as the major means of Ca²⁺ entry during prolonged depolarizations or repetitive activity (Bannister and Beam, 2009;Bannister et al., 2009). Such Ca²⁺ entry is enhanced in both Het and Hom R163C myotubes in response to [K⁺]_e depolarization and electrical pulse trains (Yang et al., 2007a;Cherednichenko et al., 2008). Here, we have examined the impact of the R163C mutation on external Ca²⁺ effects in more detail. Exposure of WT and Het and Hom R163C myotubes to low Ca²⁺ solution (8.7 × 10⁻⁶ M/5 mM Mg²⁺) did not modify initial Ca²⁺ peak, but it dramatically altered the time course of the Ca²⁺ transients, making their duration shorter and their rate of decay faster in all three genotypes (Fig. 3). The integral of the Ca²⁺ transient was reduced by 62 ± 5.8% (n = 9) in WT, 74 ± 7% (n = 14) in Het R163C, and by 80 ± 9.3% (n = 12) in Hom R163C in low [Ca²⁺]_e solution, and the rate of Ca²⁺ decay was increased from 0.107 ± 0.004 s⁻¹ (n = 11) to 0.233 ± 0.006 s⁻¹ (n = 9), from 0.068 ± 0.004 s⁻¹(n = 13) to 0.144 ± 0.004 s⁻¹ (n = 14), and from 0.037 ± 0.003 s⁻¹ (n = 17) to 0.137 ± 0.005 s⁻¹ (n = 12) in WT, Het, and Hom, respectively. The changes in the transient integral and rate of decay were fully reversible in a third depolarization for all genotypes, when [Ca²⁺]_e was restored in the bath solution (unpublished data).

Effect of Ca²⁺ entry blockers on K⁺-induced Ca²⁺ transients

Because removal of external Ca²⁺ would be expected not only to eliminate Ca²⁺ entry, but also to accelerate inactivation of the voltage sensor for ECC (Rios and Brum, 1987), we also examined the effect of two organic Ca²⁺ entry blockers, nifedipine and SKF-96365 (Almers and Palade, 1981;Rivet et al., 1989;Leung and Kwan, 1999;Araya et al., 2003;Bannister et al., 2009), in the presence of Ca²⁺ replete external solutions.

Exposure to 10 µM nifedipine in the presence of normal external Ca²⁺ concentrations did not affect Ca²⁺ transient amplitude, but it accelerated the mean rate of decay from 0.107 ± 0.004 s⁻¹ (n = 11) to 0.135 ± 0.005 s⁻¹ (n = 11) in WT (∼30%), and from 0.037 ± 0.003 s⁻¹ (n = 17) to 0.117 ± 0.002 s⁻¹ (n = 16) in Hom R163C (∼70%) myotubes (P < 0.001;Fig. 4 A). Exposure of WT and Hom R163C myotubes to 20 µM SKF-96365 did not lower Ca²⁺ transient amplitude, but it accelerated the mean rate of decay from 0.107 ± 0.004 s⁻¹ (n = 11) to 0.146 ± 0.005 s⁻¹ (n = 9) in WT myotubes (∼27%), and from 0.037 ± 0.003 s⁻¹ (n = 17) to 0.072 ± 0.004 s⁻¹ (n = 13) in Hom R163C (∼49%) myotubes (P < 0.001;Fig. 4 B). To test whether the effects of nifedipine orSKF96365 on the decay rate of the Ca²⁺ transients could be explained by their ability to partially depolarize the myotubes’ membrane at rest, or affect a change in the magnitude of the depolarization induced by 60 mM [K⁺]_e, membrane potentials were measured directly under these experimental conditions. Neither nifedipine nor SKF-96365 modified the resting membrane potential or the ability of 60 mM [K⁺]_e to depolarize the myotubes to the expected membrane potential (unpublished data).

The reduced rate of ECC voltage sensor inactivation that results from the R163C mutation is apparent when Ni²⁺ is substituted for Ca²⁺

Although both nifedipine and SKF-96365 accelerated Ca²⁺ transient decay, the decay rates remained different between WT and Hom myotubes, providing further support for the hypothesis that the R163C mutation affects the rate at which the DHPR transitions into the ECC-inactivated state. To further test this hypothesis, we examined the effect of replacement of external Ca²⁺ by Ni²⁺. Previous investigations in amphibian muscle have shown that when Ni²⁺ is used to replace Ca²⁺ in the extracellular medium, the normal time course of K⁺ contractures is maintained (Caputo, 1981;Lorković and Rüdel, 1983), despite the fact that Ni²⁺ blocks Ca²⁺ current conducted by amphibian skeletal L-type channels (Almers and Palade, 1981;Obejero-Paz et al., 2008).Fig. 5 shows superimposed averaged records from experiments in which WT and R163C Het and Hom myotubes were exposed to 60 mM [K⁺]_e under three different experimental conditions: in the presence of (1) 1.8 × 10⁻³ M Ca²⁺, (2) 8.7 × 10⁻⁶ M Ca²⁺, and (3) 8.7 × 10⁻⁶ M Ca²⁺ supplemented with 2 × 10⁻³ M Ni²⁺ (see Materials and methods for details). As shown above, the removal of Ca²⁺ significantly accelerated the rate of decay compared with the response in normal Ca²⁺ solutions. Importantly, the addition of Ni²⁺ to low [Ca²⁺]_e solutions also resulted in prolongation of the K⁺-evoked Ca²⁺ transients in WT, Het, and Hom myotubes, although it did not restore the rate of decay to control levels. Under all three conditions, the decay rate was significantly slower in Hom and Het myotubes compared with WT. If the decay rates of the Ca²⁺ transients in the presence of Ni²⁺ are taken to indicate the normal course of SR Ca²⁺ release without any influence from Ca²⁺ entry, the fraction of the total Ca²⁺ release that is presumably due to the inactivation of the DHPR caused by the lack of extracellular Ca²⁺ was 35.7% of the area under the curve in WT, 44.1% in Het R163C, and 64.3% in Hom R163C myotubes. These results suggest that the shortening of the Ca²⁺ transient in low Ca²⁺ solution was a combined consequence of accelerated inactivation of the DHPR voltage sensor and decreased depolarization-induced Ca²⁺ entry (seeTable II for decay rates). Furthermore, these data show that the lack of extracellular Ca²⁺ affects the inactivation of the DHPR ECC voltage sensor in the Het and Hom R163C myotubes to a much greater extent than in WT myotubes.

Cation entry is enhanced by R163C and can be blocked by Ni²⁺

We directly measured the differences in cation entry in response to membrane depolarization using the Mn²⁺ quench technique in Hom R163C and WT myotubes.Fig. 6 A shows representative Fura-2 emission traces from Hom R163C and WT myotubes before and after stimulation with 60 mM KCl in the presence and absence of Ni²⁺. As summarized inFig. 6 B, these data show the average rate of Mn²⁺ quench measured during the linear phase of quench after KCl exposure was significantly greater in Hom R163C myotubes than in WT myotubes (P < 0.01). Furthermore, cation entry was almost completely abolished in both groups of myotubes by the addition of 5 mM Ni²⁺.

Double K⁺ pulse protocol to assess DHPR voltage sensor inactivation

Depolarization converts resting DHPR voltage sensors into their active state, after which they spontaneously change conformation and transition into their inactive state. The amount of SR Ca²⁺ release in response to depolarization is proportional to the degree that the voltage sensors are in their active state (Dulhunty and Gage, 1988;Dulhunty, 1992), when the T-tubule is depolarized. WT and R163C Het and Hom myotubes were initially exposed to 60 mM [K⁺]_e for 10 s (Fig. 7,Int₁), and then returned to normal mammalian Ringer’s solution for 3, 5, or 10 s (Fig. 7, Δt), and then reexposed to 60 mM [K⁺]_e for 10 s (Fig. 7,Int₂). We observed that washout of the elevated K⁺ solution with normal Ringer’s solution immediately stopped the Ca²⁺ transient in all three genotypes, an effect that can be attributed to the repolarization of the plasma membrane. However, the amplitude of the Ca²⁺ transient triggered by reexposure to high [K⁺]_e was highly genotype dependent (Fig. 7,Int₂). The integral of the Ca²⁺ transient duringlnt₂ in Hom R163C myotubes was not significantly different from the integral duringInt₁ for all interpulse intervals (Fig. 7; P > 0.05, Tukey’s multiple tests). In Het R163C myotubes,lnt₂ was significantly smaller thanInt₁ at 3 s, but not significantly different fromInt₁ at 5 and 10 s (Fig. 7). In WT myotubes, on the other hand,Int₂ was significantly lower thanInt₁ at all three intervals tested (i.e., 3, 5, and 10 s; P < 0.001). These results indicate that the DHPR voltage sensor inactivates more slowly in MHS myotubes than in WT.

1. Almers W., Palade P.T.1981. Slow calcium and potassium currents across frog muscle membrane: measurements with a vaseline-gap technique. J. Physiol.312:159–176 [DOI] [PMC free article] [PubMed] [Google Scholar]
2. Araya R., Liberona J.L., Cárdenas J.C., Riveros N., Estrada M., Powell J.A., Carrasco M.A., Jaimovich E.2003. Dihydropyridine receptors as voltage sensors for a depolarization-evoked, IP3R-mediated, slow calcium signal in skeletal muscle cells. J. Gen. Physiol.121:3–1610.1085/jgp.20028671 [DOI] [PMC free article] [PubMed] [Google Scholar]
3. Armstrong C.M., Bezanilla F.M., Horowicz P.1972. Twitches in the presence of ethylene glycol bis(-aminoethyl ether)-N,N’-tetracetic acid. Biochim. Biophys. Acta.267:605–60810.1016/0005-2728(72)90194-6 [DOI] [PubMed] [Google Scholar]
4. Bannister R.A., Beam K.G.2009. The cardiac alpha(1C) subunit can support excitation-triggered Ca²⁺ entry in dysgenic and dyspedic myotubes. Channels (Austin).3:268–273 [DOI] [PMC free article] [PubMed] [Google Scholar]
5. Bannister R.A., Pessah I.N., Beam K.G.2009. The skeletal L-type Ca²⁺ current is a major contributor to excitation-coupled Ca²⁺ entry. J. Gen. Physiol.133:79–9110.1085/jgp.200810105 [DOI] [PMC free article] [PubMed] [Google Scholar]
6. Bannister R.A., Estève E., Eltit J.M., Pessah I.N., Allen P.D., López J.R., Beam K.G.2010. A malignant hyperthermia–inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels. J. Gen. Physiol.135:629–640 [DOI] [PMC free article] [PubMed] [Google Scholar]
7. Bianchi C.P., Shanes A.M.1959. Calcium influx in skeletal muscle at rest, during activity, and during potassium contracture. J. Gen. Physiol.42:803–81510.1085/jgp.42.4.803 [DOI] [PMC free article] [PubMed] [Google Scholar]
8. Blinks J.R., Rüdel R., Taylor S.R.1978. Calcium transients in isolated amphibian skeletal muscle fibres: detection with aequorin. J. Physiol.277:291–323 [DOI] [PMC free article] [PubMed] [Google Scholar]
9. Bolaños P., Caputo C., Velaz L.1986. Effects of calcium, barium and lanthanum on depolarization-contraction coupling in skeletal muscle fibres of Rana pipiens. J. Physiol.370:39–60 [DOI] [PMC free article] [PubMed] [Google Scholar]
10. Brum G., Ríos E., Stéfani E.1988. Effects of extracellular calcium on calcium movements of excitation-contraction coupling in frog skeletal muscle fibres. J. Physiol.398:441–473 [DOI] [PMC free article] [PubMed] [Google Scholar]
11. Caputo C.1972a. The effect of low temperature on the excitation-contraction coupling phenomena of frog single muscle fibres. J. Physiol.223:461–482 [DOI] [PMC free article] [PubMed] [Google Scholar]
12. Caputo C.1972b. The time course of potassium contractures of single muscle fibres. J. Physiol.223:483–505 [DOI] [PMC free article] [PubMed] [Google Scholar]
13. Caputo C.1976. The effect of caffeine and tetracaine on the time course of potassium contractures of single muscle fibres. J. Physiol.255:191–207 [DOI] [PMC free article] [PubMed] [Google Scholar]
14. Caputo C.1981. Nickel substitution for calcium and the time course of potassium contractures of single muscle fibres. J. Muscle Res. Cell Motil.2:167–18210.1007/BF00711867 [DOI] [PubMed] [Google Scholar]
15. Caputo C., Bolaños P.1994. Fluo-3 signals associated with potassium contractures in single amphibian muscle fibres. J. Physiol.481:119–128 [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Caputo C., Gimenez M.1967. Effects of external calcium deprivation on single muscle fibers. J. Gen. Physiol.50:2177–219510.1085/jgp.50.9.2177 [DOI] [PMC free article] [PubMed] [Google Scholar]
17. Chelu M.G., Goonasekera S.A., Durham W.J., Tang W., Lueck J.D., Riehl J., Pessah I.N., Zhang P., Bhattacharjee M.B., Dirksen R.T., Hamilton S.L.2006. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J.20:329–330 [DOI] [PubMed] [Google Scholar]
18. Cherednichenko G., Hurne A.M., Fessenden J.D., Lee E.H., Allen P.D., Beam K.G., Pessah I.N.2004. Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc. Natl. Acad. Sci. USA.101:15793–1579810.1073/pnas.0403485101 [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Cherednichenko G., Ward C.W., Feng W., Cabrales E., Michaelson L., Samso M., López J.R., Allen P.D., Pessah I.N.2008. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol. Pharmacol.73:1203–121210.1124/mol.107.043299 [DOI] [PMC free article] [PubMed] [Google Scholar]
20. Cota G., Stefani E.1981. Effects of external calcium reduction on the kinetics of potassium contractures in frog twitch muscle fibres. J. Physiol.317:303–316 [DOI] [PMC free article] [PubMed] [Google Scholar]
21. Dirksen R.T., Beam K.G.1999. Role of calcium permeation in dihydropyridine receptor function. Insights into channel gating and excitation–contraction coupling. J. Gen. Physiol.114:393–40310.1085/jgp.114.3.393 [DOI] [PMC free article] [PubMed] [Google Scholar]
22. Dulhunty A.F.1992. The voltage-activation of contraction in skeletal muscle. Prog. Biophys. Mol. Biol.57:181–22310.1016/0079-6107(92)90024-Z [DOI] [PubMed] [Google Scholar]
23. Dulhunty A.F., Gage P.W.1988. Effects of extracellular calcium concentration and dihydropyridines on contraction in mammalian skeletal muscle. J. Physiol.399:63–80 [DOI] [PMC free article] [PubMed] [Google Scholar]
24. Ebata H., Mills J.S., Nemcek K., Johnson J.D.1990. Calcium binding to extracellular sites of skeletal muscle calcium channels regulates dihydropyridine binding. J. Biol. Chem.265:177–182 [PubMed] [Google Scholar]
25. Frank G.B.1960. Effects of changes in extracellular calcium concentration on the potassium-induced contracture of frog’s skeletal muscle. J. Physiol.151:518–538 [DOI] [PMC free article] [PubMed] [Google Scholar]
26. Gallant E.M., Lentz L.R.1992. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia. Am. J. Physiol.262:C422–C426 [DOI] [PubMed] [Google Scholar]
27. Gallant E.M., Gronert G.A., Taylor S.R.1982. Cellular membrane potentials and contractile threshold in mammalian skeletal muscle susceptible to malignant hyperthermia. Neurosci. Lett.28:181–18610.1016/0304-3940(82)90149-5 [DOI] [PubMed] [Google Scholar]
28. Hodgkin A.L., Horowicz P.1959. The influence of potassium and chloride ions on the membrane potential of single muscle fibres. J. Physiol.148:127–160 [DOI] [PMC free article] [PubMed] [Google Scholar]
29. Hodgkin A.L., Horowicz P.1960a. The effect of sudden changes in ionic concentrations on the membrane potential of single muscle fibres. J. Physiol.153:370–385 [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Hodgkin A.L., Horowicz P.1960b. Potassium contractures in single muscle fibres. J. Physiol.153:386–403 [DOI] [PMC free article] [PubMed] [Google Scholar]
31. Jong D.S., Pape P.C., Baylor S.M., Chandler W.K.1995. Calcium inactivation of calcium release in frog cut muscle fibers that contain millimolar EGTA or Fura-2. J. Gen. Physiol.106:337–38810.1085/jgp.106.2.337 [DOI] [PMC free article] [PubMed] [Google Scholar]
32. Jurkat-Rott K., McCarthy T., Lehmann-Horn F.2000. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve.23:4–17 [DOI] [PubMed] [Google Scholar]
33. Leung Y.M., Kwan C.Y.1999. Current perspectives in the pharmacological studies of store-operated Ca²⁺ entry blockers. Jpn. J. Pharmacol.81:253–25810.1254/jjp.81.253 [DOI] [PubMed] [Google Scholar]
34. López J.R., Alamo L., Caputo C., DiPolo R., Vergara S.1983. Determination of ionic calcium in frog skeletal muscle fibers. Biophys. J.43:1–410.1016/S0006-3495(83)84316-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
35. López J.R., Alamo L., Caputo C., Wikinski J., Ledezma D.1985. Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. Muscle Nerve.8:355–35810.1002/mus.880080502 [DOI] [PubMed] [Google Scholar]
36. López J.R., Allen P.D., Alamo L., Jones D., Sreter F.A.1988. Myoplasmic free [Ca²⁺] during a malignant hyperthermia episode in swine. Muscle Nerve.11:82–8810.1002/mus.880110113 [DOI] [PubMed] [Google Scholar]
37. López J.R., Linares N., Pessah I.N., Allen P.D.2005. Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca²⁺]_i. Am. J. Physiol. Cell Physiol.288:C606–C61210.1152/ajpcell.00297.2004 [DOI] [PubMed] [Google Scholar]
38. Lorković H., Rüdel R.1983. Influence of divalent cations on potassium contracture duration in frog muscle fibres. Pflugers Arch.398:114–11910.1007/BF00581057 [DOI] [PubMed] [Google Scholar]
39. Lüttgau H.C., Spiecker W.1979. The effects of calcium deprivation upon mechanical and electrophysiological parameters in skeletal muscle fibres of the frog. J. Physiol.296:411–429 [DOI] [PMC free article] [PubMed] [Google Scholar]
40. Monnier N., Procaccio V., Stieglitz P., Lunardi J.1997. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet.60:1316–132510.1086/515454 [DOI] [PMC free article] [PubMed] [Google Scholar]
41. Nakai J., Dirksen R.T., Nguyen H.T., Pessah I.N., Beam K.G., Allen P.D.1996. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature.380:72–7510.1038/380072a0 [DOI] [PubMed] [Google Scholar]
42. Nakai J., Sekiguchi N., Rando T.A., Allen P.D., Beam K.G.1998. Two regions of the ryanodine receptor involved in coupling with L-type Ca²⁺ channels. J. Biol. Chem.273:13403–1340610.1074/jbc.273.22.13403 [DOI] [PubMed] [Google Scholar]
43. Nelson T.E.2001. Heat production during anesthetic-induced malignant hyperthermia. Biosci. Rep.21:169–17910.1023/A:1013696124358 [DOI] [PubMed] [Google Scholar]
44. Nelson T.E.2002. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr. Mol. Med.2:347–36910.2174/1566524023362429 [DOI] [PubMed] [Google Scholar]
45. Obejero-Paz C.A., Gray I.P., Jones S.W.2008. Ni²⁺ block of Ca_V3.1 (α1G) T-type calcium channels. J. Gen. Physiol.132:239–25010.1085/jgp.200809988 [DOI] [PMC free article] [PubMed] [Google Scholar]
46. Palade P.T., Almers W.1985. Slow calcium and potassium currents in frog skeletal muscle: their relationship and pharmacologic properties. Pflugers Arch.405:91–10110.1007/BF00584528 [DOI] [PubMed] [Google Scholar]
47. Rando T.A., Blau H.M.1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol.125:1275–128710.1083/jcb.125.6.1275 [DOI] [PMC free article] [PubMed] [Google Scholar]
48. Rios E., Brum G.1987. Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature.325:717–72010.1038/325717a0 [DOI] [PubMed] [Google Scholar]
49. Rivet M., Cognard C., Raymond G.1989. The slow inward calcium current is responsible for a part of the contraction of patch-clamped rat myoballs. Pflugers Arch.413:316–31810.1007/BF00583547 [DOI] [PubMed] [Google Scholar]
50. Robinson R., Carpenter D., Shaw M.A., Halsall J., Hopkins P.2006. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat.27:977–98910.1002/humu.20356 [DOI] [PubMed] [Google Scholar]
51. Simon B.J., Klein M.G., Schneider M.F.1991. Calcium dependence of inactivation of calcium release from the sarcoplasmic reticulum in skeletal muscle fibers. J. Gen. Physiol.97:437–47110.1085/jgp.97.3.437 [DOI] [PMC free article] [PubMed] [Google Scholar]
52. Smith J.S., Coronado R., Meissner G.1985. Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature.316:446–44910.1038/316446a0 [DOI] [PubMed] [Google Scholar]
53. Snowdowne K.W.1985. Subcontracture depolarizations increase sarcoplasmic ionized calcium in frog skeletal muscle. Am. J. Physiol.248:C520–C526 [DOI] [PubMed] [Google Scholar]
54. Stefani E., Chiarandini D.J.1973. Skeletal muscle: dependence of potassium contractures on extracellular calcium. Pflugers Arch.343:143–15010.1007/BF00585709 [DOI] [PubMed] [Google Scholar]
55. Suarez-Isla B.A., Orozco C., Heller P.F., Froehlich J.P.1986. Single calcium channels in native sarcoplasmic reticulum membranes from skeletal muscle. Proc. Natl. Acad. Sci. USA.83:7741–774510.1073/pnas.83.20.7741 [DOI] [PMC free article] [PubMed] [Google Scholar]
56. Tanabe T., Beam K.G., Adams B.A., Niidome T., Numa S.1990. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature.346:567–56910.1038/346567a0 [DOI] [PubMed] [Google Scholar]
57. Treves S., Anderson A.A., Ducreux S., Divet A., Bleunven C., Grasso C., Paesante S., Zorzato F.2005. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord.15:577–58710.1016/j.nmd.2005.06.008 [DOI] [PubMed] [Google Scholar]
58. Yang T., Ta T.A., Pessah I.N., Allen P.D.2003. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J. Biol. Chem.278:25722–2573010.1074/jbc.M302165200 [DOI] [PubMed] [Google Scholar]
59. Yang T., Riehl J., Esteve E., Matthaei K.I., Goth S., Allen P.D., Pessah I.N., Lopez J.R.2006. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology.105:1164–117510.1097/00000542-200612000-00016 [DOI] [PubMed] [Google Scholar]
60. Yang T., Allen P.D., Pessah I.N., Lopez J.R.2007a. Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J. Biol. Chem.282:37471–3747810.1074/jbc.M701379200 [DOI] [PubMed] [Google Scholar]
61. Yang T., Esteve E., Pessah I.N., Molinski T.F., Allen P.D., López J.R.2007b. Elevated resting [Ca²⁺]_i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am. J. Physiol. Cell Physiol.292:C1591–C159810.1152/ajpcell.00133.2006 [DOI] [PubMed] [Google Scholar]